{"record":{"code":"W-02872","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ","buyer":"","amount":153251.65,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20260002969204-2455","ocds-5wno2w-CE-20260002969248-2455","ocds-5wno2w-CE-20260002969254-2455"],"id":"W-02872","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 153,252 USD (≈ $153,252); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20260002969204-2455, ocds-5wno2w-CE-20260002969248-2455, ocds-5wno2w-CE-20260002969254-2455; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","153,252",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02872",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20260002969204-2455",null],["Reference","ocds-5wno2w-CE-20260002969248-2455",null],["Reference","ocds-5wno2w-CE-20260002969254-2455",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 153,252 USD (≈ $153,252); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20260002969204-2455, ocds-5wno2w-CE-20260002969248-2455, ocds-5wno2w-CE-20260002969254-2455; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"067778e0"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Ecuador","iso2":"EC","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":84,"new_today":0,"on_pages":84,"full_list":[],"html":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/index.json"}